Company Profile

TeselaGen Inc (AKA: Teselagen Biotechnology Inc)
Profile last edited on: 11/4/16      CAGE: 6ELV9      UEI:

Business Identifier: DNA design & fabrication integrating research in modern cloning, PCR, direct synthesis, and gene editing methodologies.
Year Founded
2011
First Award
2012
Latest Award
2017
Program Status
Inactive
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

1700 4th Street MC 2522
San Francisco, CA 94158
   (650) 387-5932
   contact@teselagen.com
   www.teselagen.com
Location: Single
Congr. District: 12
County: San Francisco

Public Profile

TeselaGen Biotechnology, Inc. is a synthetic biology company that produces and distributes DNA assembly software that optimizes molecular design for cloning and analyzes genetic sequences. The company provides computerized methods for metabolic pathway design and engineering of novel biological circuits. The company’s solutions help in enabling scientists utilize technology to explore and construct synthetic genomes. Their mission is to provide a design-build-test-evolve platform for automated combinatorial DNA assembly, meeting their customer's need for well managed, scalable, and very low-cost DNA construction and assembly. TeselaGen provides a revolutionary DNA design and assembly protocol generation service decoupling DNA design from any underlying assembly method, providing the most advanced Bio CAD/CAM system available. Taking full advantage of both in-house DNA constructs and the rapidly falling cost of de novo DNA synthesis, TeselaGen optimizes across a broad range of modern assembly techniques to produce fully scar-less DNA sequence assembly instructions ready for use at the bench or via automation. With TeselaGen's proprietary technology, these advances are now available for biologists at all levels of expertise who wish to assemble DNA simply, reliably, inexpensively, and with high fidelity. TeselaGen is the only scar-less DNA design and assembly system that can automatically and comprehensively construct and manage the combinatorial libraries required to implement modern screening and directed evolution efforts. TeselaGen allows for the incremental accumulation and application of design rules to automatically eliminate known dead end constructs as new biological knowledge is acquired - essential for success when working with combinatorial libraries with millions of constructs. With protocol optimization built in, TeselaGen automatically identifies assembly incompatibilities and suggests workarounds. Applications for TeselaGen's technology include: the production of medicine and chemicals, biofuels, and the encoding of enzymes for toxic waste reduction.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
10-14
Revenue Range
1M-1.5M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
N/A

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2017 2 NSF $1,446,000
Project Title: A Synthetic Biology Design-Build-Test Platform for Automated Combinatorial DNA Assembly
2012 1 NSF $150,000
Project Title: Directed DNA Synthesis and Assembly

Key People / Management

  Michael Fero -- Founder and Chief Executive Officer

  Eduardo Abeliuk -- Founder and Chief Technology Officer

  Nathan Hillson -- Founder and Chief Scientific Officer